Main Menu
Menu

Fact Checks

Publish Date
BlogFact Checks
Fact Check: The Myth of So-Called “Royalty Free” and “Open” Standards

The word “open” has become increasingly misused in the world of technology standards. In policy and antitrust terms, an open standard is...

Fact ChecksResources
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology

The Patent Eligibility Restoration Act of 2025 (PERA), sponsored by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE), is bipartisan legislation that...

Fact ChecksResources
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences

The Patent Eligibility Restoration Act of 2025 (PERA), sponsored by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE), is bipartisan legislation that...

BlogFact Checks
Fact Check: Separating Fact From Fiction in Recent FTC/DOJ Listening Sessions on Patents in the Drug Industry

Myths about how patent rights affect competition within the drug industry remain a pressing issue for innovators. Although strong patents play a...

BlogFact Checks
Fact Check: IP Protections Power the U.S. Innovation Economy. MFN Would Undermine this System.

In recent months, federal policymakers have renewed calls for “Most-Favored-Nation” (MFN) drug pricing, which would tie the price of medicines in the...

BlogFact Checks
Fact Check: Setting the Record Straight on Standard-Essential Patents and Innovation

Earlier this year, a coalition of technology industry lobbyists sent a letter to President Trump urging his administration to weaken protections for...

BlogFact Checks
Fact Check: PERA and the PREVAIL Act Would Bolster, Not Harm, Inventors

A bipartisan group of legislators led by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE) recently reintroduced two critical bills to Congress:...

BlogFact Checks
Two IP-Related Bills Would Harm U.S. Innovation, Not Help It

Congress is considering several ill-conceived bills that purport to address abuses in the patent system, but would in reality weaken core intellectual...

BlogFact Checks
Fact Check: Misguided Attacks on Follow-On Patents Would Harm Patients

Critics of the U.S. patent system are increasingly targeting follow-on innovation in the biopharmaceutical sector. In an effort to weaken follow-on patents...

BlogFact Checks
Fact Check: Examining Claims about China’s IP Practices

Discussions about China’s treatment of intellectual property have recently intensified in Washington, with some policymakers weighing more drastic measures to counteract perceived...

BlogFact Checks
Fact Check: The U.S. Patent System Upholds High Standards of Quality

Opponents of patent rights continue to propagate the false narrative that large numbers of “bad patents” pose an existential threat to inventors...

BlogFact Checks
Fact Check: PERA and the PREVAIL Act

The Patent Eligibility Restoration Act (PERA) and the Promoting and the Respecting Economically Vital American Innovation Leadership Act (PREVAIL) Act have continued...

Blog:

Blog, Fact Checks:

Fact Check: The Myth of So-Called “Royalty Free” and “Open” Standards,

10/30/2025
Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology,

09/25/2025
Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences,

09/25/2025
Blog:

Blog, Fact Checks:

Fact Check: Separating Fact From Fiction in Recent FTC/DOJ Listening Sessions on Patents in the Drug Industry,

09/19/2025
Blog:

Blog, Fact Checks:

Fact Check: IP Protections Power the U.S. Innovation Economy. MFN Would Undermine this System.,

08/14/2025
Blog:

Blog, Fact Checks:

Fact Check: Setting the Record Straight on Standard-Essential Patents and Innovation,

07/25/2025
Blog:

Blog, Fact Checks:

Fact Check: PERA and the PREVAIL Act Would Bolster, Not Harm, Inventors,

06/18/2025
Fact Checks:

Blog, Fact Checks:

Two IP-Related Bills Would Harm U.S. Innovation, Not Help It,

05/21/2025
Blog:

Blog, Fact Checks:

Fact Check: Misguided Attacks on Follow-On Patents Would Harm Patients,

04/16/2025
Blog:

Blog, Fact Checks:

Fact Check: Examining Claims about China’s IP Practices,

03/26/2025
Blog:

Blog, Fact Checks:

Fact Check: The U.S. Patent System Upholds High Standards of Quality,

02/27/2025
Blog:

Blog, Fact Checks:

Fact Check: PERA and the PREVAIL Act,

01/09/2025
Scroll to Top